CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Microbot Medical Inc. - MBOT CFD

1.23
1.61%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.07
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026207 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026207%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003985 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003985%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 1.24
Open* 1.23
1-Year Change* -72.85%
Day's Range* 1.22 - 1.24
52 wk Range 1.00-4.65
Average Volume (10 days) 50.14K
Average Volume (3 months) 1.92M
Market Cap 15.80M
P/E Ratio -100.00K
Shares Outstanding 11.71M
Revenue N/A
EPS -1.20
Dividend (Yield %) N/A
Beta 3.19
Next Earnings Date Nov 24, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Nov 30, 2023 1.24 -0.01 -0.80% 1.25 1.28 1.21
Nov 29, 2023 1.24 -0.06 -4.62% 1.30 1.32 1.21
Nov 28, 2023 1.28 -0.06 -4.48% 1.34 1.34 1.28
Nov 27, 2023 1.34 -0.03 -2.19% 1.37 1.37 1.29
Nov 24, 2023 1.31 0.00 0.00% 1.31 1.42 1.31
Nov 22, 2023 1.30 -0.05 -3.70% 1.35 1.35 1.28
Nov 21, 2023 1.33 0.00 0.00% 1.33 1.39 1.30
Nov 20, 2023 1.35 0.01 0.75% 1.34 1.44 1.34
Nov 17, 2023 1.34 0.01 0.75% 1.33 1.36 1.33
Nov 16, 2023 1.33 -0.04 -2.92% 1.37 1.38 1.33
Nov 15, 2023 1.40 0.06 4.48% 1.34 1.43 1.32
Nov 14, 2023 1.36 0.03 2.26% 1.33 1.38 1.33
Nov 13, 2023 1.32 0.01 0.76% 1.31 1.33 1.27
Nov 10, 2023 1.32 -0.06 -4.35% 1.38 1.38 1.30
Nov 9, 2023 1.36 -0.08 -5.56% 1.44 1.44 1.35
Nov 8, 2023 1.46 0.09 6.57% 1.37 1.51 1.37
Nov 7, 2023 1.36 0.03 2.26% 1.33 1.37 1.33
Nov 6, 2023 1.34 -0.05 -3.60% 1.39 1.41 1.28
Nov 3, 2023 1.40 0.17 13.82% 1.23 1.41 1.23
Nov 2, 2023 1.26 0.08 6.78% 1.18 1.27 1.18

Microbot Medical Inc. Events

Time (UTC) Country Event
Friday, March 29, 2024

Time (UTC)

20:00

Country

US

Event

Q4 2023 Microbot Medical Inc Earnings Release
Q4 2023 Microbot Medical Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 0 0 0 0 0
Total Operating Expense 13.281 11.357 9.089 7.24 7.244
Selling/General/Admin. Expenses, Total 5.769 5.406 5.884 4.362 4.832
Research & Development 7.41 5.875 3.137 2.822 2.702
Operating Income -13.281 -11.357 -9.089 -7.24 -7.244
Interest Income (Expense), Net Non-Operating 0.118 0.044 -0.08 -0.103 -0.016
Other, Net
Net Income Before Taxes -13.168 -11.313 -9.169 -7.247 -7.26
Net Income After Taxes -13.168 -11.313 -9.169 -7.247 -7.26
Net Income Before Extra. Items -13.168 -11.313 -9.169 -7.247 -7.26
Net Income -13.168 -11.313 -9.169 -7.247 -7.26
Income Available to Common Excl. Extra. Items -13.168 -11.313 -9.169 -7.247 -7.26
Income Available to Common Incl. Extra. Items -13.168 -11.313 -9.169 -7.247 -7.26
Diluted Net Income -13.168 -11.313 -9.169 -7.247 -7.26
Diluted Weighted Average Shares 7.26034 7.10813 7.11775 4.26721 2.90425
Diluted EPS Excluding Extraordinary Items -1.81369 -1.59156 -1.28819 -1.6983 -2.49978
Diluted Normalized EPS -1.813 -1.59156 -1.28819 -1.7208 -2.49978
Unusual Expense (Income)
Depreciation / Amortization 0.102 0.076 0.068 0.084 0.054
Other Operating Expenses, Total 0 -0.028 -0.344
Gain (Loss) on Sale of Assets -0.005 0 0.096 0
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 0 0 0 0 0
Total Operating Expense 2.324 2.919 3.068 3.474 3.563
Selling/General/Admin. Expenses, Total 0.959 1.302 1.184 1.521 1.37
Research & Development 1.365 1.617 1.884 1.953 2.193
Operating Income -2.324 -2.919 -3.068 -3.474 -3.563
Interest Income (Expense), Net Non-Operating 0.037 0.066 0.075 0.006 0.05
Net Income Before Taxes -2.287 -2.853 -2.998 -3.468 -3.513
Net Income After Taxes -2.287 -2.853 -2.998 -3.468 -3.513
Net Income Before Extra. Items -2.287 -2.853 -2.998 -3.468 -3.513
Net Income -2.287 -2.853 -2.998 -3.468 -3.513
Income Available to Common Excl. Extra. Items -2.287 -2.853 -2.998 -3.468 -3.513
Income Available to Common Incl. Extra. Items -2.287 -2.853 -2.998 -3.468 -3.513
Diluted Net Income -2.287 -2.853 -2.998 -3.468 -3.513
Diluted Weighted Average Shares 9.19881 8.0133 7.71698 7.10813 7.10813
Diluted EPS Excluding Extraordinary Items -0.24862 -0.35603 -0.38849 -0.48789 -0.49422
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.24862 -0.35603 -0.38785 -0.48789 -0.49422
Gain (Loss) on Sale of Assets -0.005
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 8.814 15.879 25.253 35.936 5.831
Cash and Short Term Investments 8.205 15.492 24.648 31.292 5.238
Cash & Equivalents 2.442 13.493 19.65 28.771 5.238
Total Receivables, Net 0.103 0.174 0.07 0.101 0.065
Prepaid Expenses 0.429 0.126 0.451 0.185 0.091
Other Current Assets, Total 0.077 0.087 0.084 4.358 0.437
Total Assets 9.537 16.767 26.279 37.126 6.09
Property/Plant/Equipment, Total - Net 0.723 0.888 1.026 1.19 0.259
Property/Plant/Equipment, Total - Gross 1.11 1.177 1.239 1.335 0.391
Accumulated Depreciation, Total -0.387 -0.289 -0.213 -0.145 -0.132
Total Current Liabilities 2.069 1.984 1.345 4.826 4.76
Accounts Payable 0.116 0.279 0.275 0.284 0.63
Accrued Expenses 1.953 1.705 1.07 0.33 3.442
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 4.212 0.688
Total Liabilities 2.248 2.386 1.971 5.586 4.768
Total Long Term Debt 0 0 0 0 0
Long Term Debt
Other Liabilities, Total 0.179 0.402 0.626 0.76 0.008
Total Equity 7.289 14.381 24.308 31.54 1.322
Common Stock 0.08 0.072 0.072 0.072 0.031
Additional Paid-In Capital 75.97 69.902 68.516 69.954 32.53
Retained Earnings (Accumulated Deficit) -68.761 -55.593 -44.28 -35.111 -27.864
Other Equity, Total
Total Liabilities & Shareholders’ Equity 9.537 16.767 26.279 37.126 6.09
Total Common Shares Outstanding 7.89063 7.10813 7.10813 7.18563 3.01234
Treasury Stock - Common 0 -3.375 -3.375
Short Term Investments 5.763 1.999 4.998 2.521
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 8.407 10.339 5.581 8.814 6.603
Cash and Short Term Investments 8.153 9.92 5.057 8.205 6.331
Cash & Equivalents 1.335 5.721 2.15 2.442 4.332
Short Term Investments 6.818 4.199 2.907 5.763 1.999
Prepaid Expenses 0.208 0.371 0.475 0.429 0.193
Other Current Assets, Total 0.046 0.048 0.049 0.077 0.079
Total Assets 8.888 10.884 6.208 9.537 7.409
Property/Plant/Equipment, Total - Net 0.481 0.545 0.627 0.723 0.806
Total Current Liabilities 1.491 1.324 1.233 2.069 1.65
Accounts Payable 0.238 0.24 0.224 0.116 0.287
Accrued Expenses 1.253 1.084 1.009 1.953 1.363
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 1.53 1.416 1.36 2.248 1.876
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 0.039 0.092 0.127 0.179 0.226
Total Equity 7.358 9.468 4.848 7.289 5.533
Common Stock 0.118 0.118 0.083 0.08 0.072
Additional Paid-In Capital 83.587 83.251 76.379 75.97 71.224
Retained Earnings (Accumulated Deficit) -76.347 -73.901 -71.614 -68.761 -65.763
Total Liabilities & Shareholders’ Equity 8.888 10.884 6.208 9.537 7.409
Total Common Shares Outstanding 11.7073 11.7073 8.13063 7.89063 7.10813
Total Receivables, Net 0.103
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -13.168 -11.313 -9.169 -7.247 -7.24
Cash From Operating Activities -11.549 -9.354 -7.252 -6.451 -5.31
Cash From Operating Activities 0.102 0.076 0.068 0.084 0.054
Non-Cash Items 1.745 1.386 1.867 0.978 1.453
Changes in Working Capital -0.228 0.497 -0.018 -0.266 0.423
Cash From Investing Activities -3.836 3.2 -2.768 -2.453 -0.223
Capital Expenditures -0.084 -0.069 -0.091 -0.216 -0.223
Cash From Financing Activities 4.324 0 -3.375 36.77 -0.018
Financing Cash Flow Items 0 -3.375 -0.018
Issuance (Retirement) of Stock, Net 4.324 36.77 0
Issuance (Retirement) of Debt, Net
Net Change in Cash -11.061 -6.154 -13.395 27.866 -5.551
Other Investing Cash Flow Items, Total -3.752 3.269 -2.677 -2.237
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -2.853 -13.168 -10.17 -6.702 -3.189
Cash From Operating Activities -3.203 -11.549 -9.086 -6.131 -3.007
Cash From Operating Activities 0.025 0.102 0.069 0.044 0.021
Non-Cash Items 0.385 1.745 1.322 0.862 0.43
Changes in Working Capital -0.76 -0.228 -0.307 -0.335 -0.269
Cash From Investing Activities 2.883 -3.836 -0.083 -0.078 -0.016
Capital Expenditures 0 -0.084 -0.083 -0.078 -0.016
Other Investing Cash Flow Items, Total 2.883 -3.752 0 0 0
Cash From Financing Activities 4.324
Financing Cash Flow Items
Net Change in Cash -0.32 -11.061 -9.169 -6.209 -3.023
Issuance (Retirement) of Stock, Net 4.324
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Chasing Value Asset Management, Inc. Investment Advisor/Hedge Fund 5.216 610657 0 2023-09-08
Armistice Capital LLC Hedge Fund 3.2906 385246 -214754 2023-06-30 MED
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.2322 261336 513 2023-06-30 LOW
Bornstein (Yoseph) Individual Investor 2.0673 242028 0 2023-09-08
BlackRock Institutional Trust Company, N.A. Investment Advisor 1.1771 137808 -13620 2023-06-30 LOW
MEDX Ventures Group LLC Venture Capital 1.1689 136847 0 2023-09-08
AlphaCentric Advisors LLC. Investment Advisor 0.8542 100000 0 2023-06-30 HIGH
Pacific View Asset Management, LLC Investment Advisor/Hedge Fund 0.8542 100000 0 2023-06-30 MED
Renaissance Technologies LLC Hedge Fund 0.7491 87695 67300 2023-06-30 HIGH
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.452 52922 0 2023-06-30 LOW
BNY Mellon Asset Management Investment Advisor 0.4385 51334 -1393 2023-09-30 LOW
Morgan Stanley Smith Barney LLC Investment Advisor 0.342 40038 4600 2023-06-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.2227 26070 0 2023-06-30 LOW
PlainsCapital Corporation Investment Advisor 0.1629 19075 19075 2023-06-30 MED
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.1149 13446 0 2023-06-30 LOW
Wells Fargo Advisors Research Firm 0.1084 12685 12550 2023-06-30 LOW
Taylor Frigon Capital Management LLC Investment Advisor 0.1068 12500 12500 2023-09-30 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 0.0874 10231 -55976 2023-06-30 LOW
Millennium Management LLC Hedge Fund 0.0873 10219 -4643 2023-06-30 HIGH
UBS Financial Services, Inc. Investment Advisor 0.0777 9100 4559 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Microbot Medical Inc. Company profile

About Microbot Medical Inc

Microbot Medical Inc. is a pre-clinical medical device company. The Company is focused on the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Its technological platforms are comprised of ViRob, TipCAT and Liberty, including certain CardioSert assets. Using the ViRob platform, Microbot is developing the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and Normal Pressure Hydrocephalus (NPH). Utilizing the Liberty and CardioSert platforms, it is developing disposable robot for various endovascular interventional procedures. ViRob technology is an autonomous crawling micro-robot, which can be controlled remotely or within the body. TipCAT is a disposable self-propelled locomotive device, designed to advance in tubular anatomies. Liberty is a disposable robotic system, designed to move guidewires and over-the-wire devices, such as microcatheters within the body’s vasculature.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Microbot Medical Inc revenues was not reported. Net loss increased 14% to $7.5M. Higher net loss reflects Research and development increase of 63% to $3.9M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.92 to -$1.05.

Equity composition

Common $.1 Par, 07/11, 250M auth., 13,784,019 issd,. Insiders control approx. 8.68%. IPO 3/92, 2.25M shares @ $11.00 by Robertson, Stephens & Co. PO 9/95, 2.3M shares @ $9.375. 10/93, *5/00, Name changed from Cytotherapeutics, Inc. PO: 11/08, 13.8M shares. 07/11, 1-for-10 reverse stock split. 05/16 1-for-12 reverse stock split.

Industry: Biotechnology & Medical Research (NEC)

25 Recreation Park Dr Suite 108
HINGHAM
MASSACHUSETTS 02043
US

Income Statement

  • Annual
  • Quarterly

News

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023
GBP

UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

10:48, 21 November 2023

People also watch

Gold

2,049.50 Price
+0.460% 1D Chg, %
Long position overnight fee -0.0196%
Short position overnight fee 0.0114%
Overnight fee time 22:00 (UTC)
Spread 0.50

XRP/USD

0.61 Price
-0.110% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

BTC/USD

38,429.45 Price
+1.690% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Oil - Crude

76.22 Price
+1.340% 1D Chg, %
Long position overnight fee -0.0165%
Short position overnight fee -0.0054%
Overnight fee time 22:00 (UTC)
Spread 0.030

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading